RESUMO
Objective:To systematically evaluate the efficacy of repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) in dysphagia after stroke.Methods:Six Chinese or English databases, including PubMed, Web of Science, Embase, CNKI, Wanfang and VIP, were searched by computer for randomized controlled trials of dysphagia after stroke with rTMS or tDCS (experimental group) from database construction to May 2023; those received conventional treatment+sham stimulation or conventional treatment only were enrolled as control group. Effective data were screened and extracted after literature quality evaluation by Cochrane. The outcome indexes included scores of penetration-aspiration scale (PAS), fiberoptic endoscopic dysphagia severity scale (FEDSS) and functional oral intake scale (FOIS). Reviewer Manager 5.4 software was used for Meta analysis of the extracted data, and mean difference ( MD) or standardized mean difference ( SMD) were used as effect indexes. Results:Twelve articles were finally included in the research literature, involving 637 subjects. Meta-analysis indicated that compared with the control group, the experimental group had significantly decreased PAS scores ( MD=-0.740, 95% CI: -1.020--0.460, P<0.001); FOIS scores in the experimental group were significantly increased compared with those in the control group ( MD=0.680, 95% CI: 0.220-1.130, P=0.003); FEDSS scores in the experimental group were significantly decreased compared with those in the control group ( SMD=-0.890, 95% CI: -1.110--0.670, P<0.001). Conclusion:The rTMS or tDCS can effectively alleviate dysphagia symptoms after stroke.
RESUMO
Objective To retrospectively analyze the clinical epidemiology features of adult idiopathic membranous nephropathy (IMN) in Zhongshan Hospital,and to investigate their therapeutic effect and its possible influence factors.Methods A total of 183 patients admitted to the Zhongshan Hospital of Fudan University and diagnosed as IMN by renal biopsy from January 2013 to December 2015 were involved.Their baseline information including demographics and pathologic was collected.Patients were followed up for at least 12 months.Serum albumin ＜ 30 g/L and 24 h urine protein ＞ 3.5g were defined as nephrotic syndrome (NS).IMN patients were divided into NS and non-NS groups and compared.Furthermore,the baseline data of remission and no remission patients were compared,and the correlations of their baseline data with conservative and immunosuppressive therapy were assessed by logistic regression analysis.Results (1) IMN accounted for 11.1％ of renal biopsy cases in our hospital,with an average age of 57 years and 59.6％ male patients.(2) Compared with patients without NS,IMN patients with NS were older,had a shorter time from the onset to receive renal biopsy,lower estimated glomerular filtration rate,and higher total cholesterol,low density lipoprotein cholesterol,triglyceride and serum creatinine (all P ＜ 0.05).(3) The effective rate of conservative treatment in IMN patients without NS was 65.7％,and the ineffective group had higher triglyceride compared with the effective group (P=0.019).(4) The effective rate of immunosuppressive therapy in IMN patients with NS was 81.2％,and low serum albumin was an independent risk factor for the poor efficacy of immunosuppressive therapy (OR=1.202,95％ CI 1.003-1.440,P=0.046).(5) The effective rate of conservative treatment in IMN patients with NS was 55.5％,and low serum albumin was an independent risk factor for the poor efficacy of conservative treatment (OR=1.629,95％CI 1.047-2.536,P=0.023).Conclusions The detection rate of IMN is increasing year by year,but the remission rate of conservative treatment is still not low in mild and moderate patients.For the patients without NS,high triglyceride may predict a poor effect of conservative treatment.Hypoproteinemia is a predictor of poor effect,no matter what a NS patient takes immunosuppressive therapy or conservative treatment.